Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy

Emi Tateishi, Teruo Noguchi, Yoichi Goto, Yoshiaki Morita, Hatsue Ishibashi-Ueda, Naoaki Yamada, Hideaki Kanzaki, Kunihiro Nishimura, Yoshihiro Miyamoto, Toshihisa Anzai, Hisao Ogawa, Satoshi Yasuda, Emi Tateishi, Teruo Noguchi, Yoichi Goto, Yoshiaki Morita, Hatsue Ishibashi-Ueda, Naoaki Yamada, Hideaki Kanzaki, Kunihiro Nishimura, Yoshihiro Miyamoto, Toshihisa Anzai, Hisao Ogawa, Satoshi Yasuda

Abstract

Objective: Late gadolinium enhancement (LGE) is not necessarily ideal for detecting diffuse myocardial fibrosis in idiopathic dilated cardiomyopathy (DCM). Since systolic blood pressure response (SBPR) during exercise has been proposed to reflect cardiac pump reserve in patients with heart failure, we wished to determine whether LGE plus SBPR is a better prognostic factor in patients with DCM.

Methods: LGE and cardiopulmonary exercise testing results in consecutive 207 patients with DCM were examined. Patients were divided into four groups according to the presence or absence of LGE and the SBPR cut-off value of +40 mm Hg according to receiver operating characteristic curve analysis: LGE-positive+SBPR <40 mm Hg (n=65), LGE-positive+SBPR ≥40 mm Hg (n=40), LGE-negative+SBPR <40 mm Hg (n=33) and LGE-negative+SBPR ≥40 mm Hg (n=69). The composite end point was cardiac death, cardiac transplantation, LV assist device implantation, life-threatening arrhythmia or heart failure.

Results: Forty-two (20%) patients developed the composite end point, with rates of 35%, 20%, 21% and 6% in patients with LGE-positive+SBPR <40 mm Hg, LGE-positive+SBPR ≥40 mm Hg, LGE-negative+SBPR <40 mm Hg and LGE-negative+SBPR ≥40 mm Hg status, respectively. Multivariable Cox regression analysis identified LGE-positive and SBPR <40 mm Hg as a significant independent predictor of cardiac events (HR 2.08, 95% CI 1.06 to 4.11, p=0.034). Of note, there was no significant difference in the cardiac event-free survival rate between the LGE-positive+SBPR ≥40 mm Hg and LGE-negative+SBPR <40 mm Hg groups (p=0.736).

Conclusions: The combination of LGE and SBPR provides more clinically relevant information for assessing the risk of cardiac events in patients with DCM than LGE status alone.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1
Figure 1
Representative examples of short-axis LGE-positive and LGE-negative images. A, B and C are short-axis images from LGE-positive patients. The typical LGE pattern in DCM is mid-wall enhancement in the interventricular septum (A). A diffuse pattern was observed in 34 out of 105 LGE-positive patients (B). Nineteen patients had focal enhancement (C, arrow). Figure 1D is a representative example of a LGE-negative case. DCM, dilated cardiomyopathy; LGE, late gadolinium enhancement.
Figure 2
Figure 2
Receiver operating characteristics (ROC) curve analysis for the development of cardiac events and flow chart of study patients on the basis of LGE and SBPR. (A) ROC curve to determine the optimal cut-off value of SBPR for cardiac events. (B) Flow diagram illustrating the number of participants. DCM, dilated cardiomyopathy; LGE, late gadolinium enhancement; ROC, receiver operator characteristics; SBPR, systolic blood pressure response.
Figure 3
Figure 3
Kaplan-Meier curves comparing the probability of all cardiac events. The LGE-positive+SBPR

References

    1. McCrohon JA, Moon JC, Prasad SK, et al. . Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54–9. 10.1161/01.CIR.0000078641.19365.4C
    1. Karamitsos TD, Francis JM, Myerson S, et al. . The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009;54:1407–24. 10.1016/j.jacc.2009.04.094
    1. Kim RJ, Wu E, Rafael A, et al. . The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445–53. 10.1056/NEJM200011163432003
    1. Kwong RY, Chan AK, Brown KA, et al. . Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733–43. 10.1161/CIRCULATIONAHA.105.570648
    1. Assomull RG, Prasad SK, Lyne J, et al. . Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977–85. 10.1016/j.jacc.2006.07.049
    1. Wu KC, Weiss RG, Thiemann DR, et al. . Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008;51:2414–21. 10.1016/j.jacc.2008.03.018
    1. Lehrke S, Lossnitzer D, Schob M, et al. . Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 2011;97:727–32. 10.1136/hrt.2010.205542
    1. de Leeuw N, Ruiter DJ, Balk AH, et al. . Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int 2001;14:299–306. 10.1007/s001470100339
    1. Chua TP, Ponikowski P, Harrington D, et al. . Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585–90. 10.1016/S0735-1097(97)00078-8
    1. Mancini DM, Eisen H, Kussmaul W, et al. . Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778–86. 10.1161/01.CIR.83.3.778
    1. Williams SG, Jackson M, Ng LL, et al. . Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology 2005;104:221–6. 10.1159/000088257
    1. Kallistratos MS, Poulimenos LE, Pavlidis AN, et al. . Prognostic significance of blood pressure response to exercise in patients with systolic heart failure. Heart Vessels 2012;27:46–52. 10.1007/s00380-010-0115-z
    1. Kitaoka H, Hitomi N, Okawa M, et al. . Prognostic significance of post-exercise blood pressure response in patients with dilated cardiomyopathy. J Cardiol 2003;42:165–71.
    1. Raphael CE, Whinnett ZI, Davies JE, et al. . Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 2009;95:56–62. 10.1136/hrt.2007.134973
    1. Richardson P, McKenna W, Bristow M, et al. . Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 1996;93:841–2. 10.1161/01.CIR.93.5.841
    1. Ise T, Hasegawa T, Morita Y, et al. . Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 2014;100:1165–72. 10.1136/heartjnl-2013-305187
    1. Yoshida A, Ishibashi-Ueda H, Yamada N, et al. . Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur J Heart Fail 2013;15:166–75. 10.1093/eurjhf/hfs206
    1. Beltrami CA, Finato N, Rocco M, et al. . The cellular basis of dilated cardiomyopathy in humans. J Mol Cell Cardiol 1995;27:291–305. 10.1016/S0022-2828(08)80028-4
    1. Gulati A, Jabbour A, Ismail TF, et al. . Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309:896–908. 10.1001/jama.2013.1363
    1. Schalla S, Bekkers SC, Dennert R, et al. . Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail 2010;12:227–31. 10.1093/eurjhf/hfq004
    1. Fagard R, Pardaens K, Vanhaecke J. Prognostic significance of exercise versus resting blood pressure in patients with chronic heart failure. J Hypertens 1999;17:1977–81. 10.1097/00004872-199917121-00030
    1. Cotter G, Williams SG, Vered Z, et al. . Role of cardiac power in heart failure. Curr Opin Cardiol 2003;18:215–22. 10.1097/00001573-200305000-00007
    1. Yamada T, Hirashiki A, Okumura T, et al. . Prognostic impact of combined late gadolinium enhancement on cardiovascular magnetic resonance and peak oxygen consumption in ambulatory patients with nonischemic dilated cardiomyopathy. J Card Fail 2014;20:825–32. 10.1016/j.cardfail.2014.08.005
    1. Messroghli DR, Radjenovic A, Kozerke S, et al. . Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141–6. 10.1002/mrm.20110
    1. Mewton N, Liu CY, Croisille P, et al. . Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:891–903. 10.1016/j.jacc.2010.11.013
    1. Iles L, Pfluger H, Phrommintikul A, et al. . Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008;52:1574–80. 10.1016/j.jacc.2008.06.049
    1. Dass S, Suttie JJ, Piechnik SK, et al. . Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012;5:726–33. 10.1161/CIRCIMAGING.112.976738
    1. Hillege HL, Nitsch D, Pfeffer MA, et al. . Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671–8. 10.1161/CIRCULATIONAHA.105.580506

Source: PubMed

3
Tilaa